On the fly News and insights, exclusive to thefly.com

2021-06-21 09:53:14 RIO Rio Tinto $81.42 / +0.34 (+0.42%) , ARCT Arcturus Therapeutics $31.70 / -3.34 (-9.53%) … 09:53 06/21/21 06/21 09:53 06/21/21 09:53	Fly Intel: Top five analyst downgrades Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rio Tinto (RIO) downgraded to Sell from Neutral at UBS with analyst Myles Allsop saying Rio's current free cash flow and dividend returns are "not sustainable" with near-term risks rising for the commodities rally. 2. Arcturus Therapeutics (ARCT) downgraded to Underweight from Equal Weight at Barclays with analyst Gena Wang continuing to see high risk for the ARCT-021 Phase 3 trial based following the failure of CureVac's (CVAC) Covid-19 vaccine. 3. CAI International (CAI) downgraded to Market Perform from Outperform at William Blair with analyst Robert Napoli viewing the Mitsubishi HC Capital deal as a "solid outcome" for CAI investors. 4. TSMC (TSM) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Charlie Chan saying given its technology leadership and potential for promising 2022 and 2023 revenue growth, TSMC is now a consensus Overweight among investors, but he fears the stock is "potentially dead money in the next 12-18 months." 5. Sykes Enterprises (SYKE) downgraded to Neutral from Outperform at Baird with analyst David Koning saying with the shares near the $54 takeout price, the analyst does not see material upside from here. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. RIO Rio Tinto $81.42 / +0.34 (+0.42%) ARCT Arcturus Therapeutics $31.70 / -3.34 (-9.53%) CAI CAI International $55.89 / -0.13 (-0.23%) TSM TSMC $113.77 / -2.1 (-1.81%) SYKE Sykes Enterprises $53.59 / +0.08 (+0.15%)	21 Jun 29 Jul 08 Dec

2021-06-21 09:53:14

RIO

Rio Tinto

$81.42 / +0.34 (+0.42%)

, ARCT

Arcturus Therapeutics

$31.70 / -3.34 (-9.53%)

… 09:53

06/21/21

06/21

09:53

06/21/21

09:53

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Rio Tinto (RIO) downgraded to Sell from Neutral at UBS with analyst Myles Allsop saying Rio's current free cash flow and dividend returns are "not sustainable" with near-term risks rising for the commodities rally. 2. Arcturus Therapeutics (ARCT) downgraded to Underweight from Equal Weight at Barclays with analyst Gena Wang continuing to see high risk for the ARCT-021 Phase 3 trial based following the failure of CureVac's (CVAC) Covid-19 vaccine. 3. CAI International (CAI) downgraded to Market Perform from Outperform at William Blair with analyst Robert Napoli viewing the Mitsubishi HC Capital deal as a "solid outcome" for CAI investors. 4. TSMC (TSM) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Charlie Chan saying given its technology leadership and potential for promising 2022 and 2023 revenue growth, TSMC is now a consensus Overweight among investors, but he fears the stock is "potentially dead money in the next 12-18 months." 5. Sykes Enterprises (SYKE) downgraded to Neutral from Outperform at Baird with analyst David Koning saying with the shares near the $54 takeout price, the analyst does not see material upside from here. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RIO

Rio Tinto